首页> 美国卫生研究院文献>The EMBO Journal >The 2.5 A X-ray crystal structure of the acid-stable proteinase inhibitor from human mucous secretions analysed in its complex with bovine alpha-chymotrypsin.
【2h】

The 2.5 A X-ray crystal structure of the acid-stable proteinase inhibitor from human mucous secretions analysed in its complex with bovine alpha-chymotrypsin.

机译:在与牛α-胰凝乳蛋白酶的复合物中分析了来自人粘液分泌的酸稳定蛋白酶抑制剂的2.5 A X射线晶体结构。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Orthorhombic crystals of the complex formed between bovine alpha-chymotrypsin and a recombinant human mucous proteinase inhibitor (SLPI) were grown. Data to 2.3 A resolution were collected on the area-detector diffractometer FAST. The crystal structure of the complex was solved by Patterson search techniques using chymotrypsin as a search model. A cyclic procedure of modeling and crystallographic refinement enabled the determination of the SLPI structure. The current crystallographic R-value is 0.19. SLPI has a boomerang-like shape with both wings comprising two well separated domains of similar architecture. In each domain the polypeptide chain is arranged like a stretched spiral. Two internal strands form a regular beta-hairpin loop which is accompanied by two external strands linked by the proteinase binding segment. The polypeptide segment of each domain is interconnected by four disulfide bridges with a connectivity pattern hitherto unobserved. The reactive site loop of the second domain has elastase and chymotrypsin binding properties. It contains the scissile peptide bond between Leu72I and Met73I and has a similar conformation to that observed in other serine proteinase protein inhibitors. Eight residues of this loop, two of the adjacent hairpin loop, the C-terminal segment and Trp30I are in direct contact with the cognate enzyme. The binding loop of the first domain (probably with anti-trypsin activity) is disordered due to proteolytic cleavage occurring in the course of crystallization.
机译:生长了牛α-胰凝乳蛋白酶和重组人粘液蛋白酶抑制剂(SLPI)之间形成的复合物的正交晶体。在面积检测器衍射仪FAST上收集到2.3A分辨率的数据。通过使用胰凝乳蛋白酶作为搜索模型的Patterson搜索技术解决了该配合物的晶体结构。循环建模和晶体学细化使得能够确定SLPI结构。当前的晶体学R值是0.19。 SLPI具有回旋镖状的形状,两个机翼包含两个彼此分离且结构相似的域。在每个结构域中,多肽链排列成螺旋状。两条内部链形成规则的β-发夹环,并伴随着两​​条通过蛋白酶结合片段连接的外部链。每个结构域的多肽片段通过四个二硫键相互连接,具有迄今未发现的连接方式。第二结构域的反应位点环具有弹性蛋白酶和胰凝乳蛋白酶结合特性。它包含Leu72I和Met73I之间的易裂肽键,并且具有与其他丝氨酸蛋白酶蛋白抑制剂相似的构象。该环的八个残基,两个相邻的发夹环,C末端片段和Trp30I与同源酶直接接触。由于在结晶过程中发生蛋白水解切割,所以第一结构域的结合环(可能具有抗胰蛋白酶活性)是无序的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号